Get Your Free Gastric Cancer Information Guide

Understanding Gastric Cancer: What You Should Know

Gastric cancer, also called stomach cancer, starts in the lining of the stomach and can spread to other parts of the body. According to the National Cancer Institute, stomach cancer accounts for approximately 1.5% of all new cancer diagnoses in the United States, with about 26,500 new cases expected annually. While this represents a relatively small percentage of overall cancer cases, gastric cancer remains a significant health concern globally, particularly in East Asia, Eastern Europe, and Central America where rates are notably higher.

The disease develops over many years, often starting with changes in the stomach lining that may not cause symptoms initially. Understanding how gastric cancer develops helps people recognize why screening and early detection matter. The stomach's role is to store and break down food, mixing it with digestive juices. When cancer cells begin forming in the innermost layer of the stomach wall, they can gradually grow deeper into surrounding tissue layers. The disease can develop as different types: adenocarcinoma is the most common form, accounting for about 90% of cases, while other types like squamous cell carcinoma or small cell carcinoma occur less frequently.

Risk factors vary and may include age (most common in people over 65), family history of stomach cancer, certain inherited genetic conditions, smoking, heavy alcohol use, obesity, and chronic stomach inflammation. Infection with H. pylori bacteria significantly increases risk, particularly in regions where this bacterium is more prevalent. Understanding these factors can help people have informed conversations with their healthcare providers about their personal risk level.

Practical Takeaway: Learning the basic facts about how gastric cancer develops and who faces higher risk provides a foundation for making informed decisions about screening discussions with your doctor.

Recognizing Symptoms and When to See a Doctor

Early-stage gastric cancer often produces no symptoms, which is why many cases are diagnosed at later stages. However, as the disease progresses, various symptoms may appear. Common signs include persistent indigestion or heartburn that doesn't respond to over-the-counter medications, difficulty swallowing (dysphagia), feeling unusually full after eating small amounts of food, stomach pain or discomfort in the upper abdomen, nausea and vomiting (sometimes with blood), loss of appetite, unexplained weight loss, and low energy levels or fatigue.

It's important to understand that these symptoms can result from many non-cancerous conditions including ulcers, gastritis, or acid reflux. Having one or more of these symptoms doesn't mean a person has gastric cancer. However, when symptoms persist for several weeks despite home care measures or changes to diet, consulting with a healthcare provider becomes important. The American Cancer Society recommends that anyone experiencing persistent digestive symptoms should discuss them with their doctor, particularly if symptoms are new and different from their usual patterns.

Certain situations warrant prompt medical attention: vomiting that contains blood or material that looks like coffee grounds, severe stomach pain, difficulty swallowing that worsens over time, or unexplained weight loss of 10 pounds or more in a short period. These signs suggest the need for medical evaluation to determine the cause. Additionally, people with family histories of gastric cancer or with known risk factors should inform their doctors so appropriate monitoring can be discussed.

Age and duration of symptoms matter in clinical evaluation. A 35-year-old experiencing indigestion for one week typically requires different assessment than a 68-year-old with the same symptoms persisting for three months. Your doctor will consider your age, symptom duration, medical history, and risk factors when determining what evaluation steps might be appropriate.

Practical Takeaway: Keep a brief record of any persistent digestive symptoms lasting more than a few weeks, noting when they occur and what makes them better or worse, to share with your healthcare provider during appointments.

Diagnostic Tests and How They Work

If a doctor suspects gastric cancer based on symptoms and physical examination, several diagnostic tests may be recommended. The most common initial test is an upper endoscopy (esophagogastroduodenoscopy or EGD), where a thin, flexible tube with a camera is passed down the throat to visualize the stomach's interior directly. This allows doctors to see abnormal areas and take tissue samples (biopsies) for laboratory analysis. The procedure typically takes 15 to 30 minutes and is often performed with sedation to keep patients comfortable. According to the American College of Gastroenterology, endoscopy remains the gold standard for visualizing the stomach and obtaining tissue samples for diagnosis.

After a tissue sample is obtained, it goes to pathology where specialists examine it under a microscope to determine whether cancer cells are present and, if so, what type and grade. This histopathological diagnosis is essential because treatment recommendations depend heavily on these findings. The grade (how abnormal the cells appear) and type of cancer help predict how quickly the disease might progress.

Additional imaging tests help determine the extent of disease if cancer is confirmed. CT scans of the abdomen and pelvis create detailed cross-sectional pictures showing the stomach, surrounding organs, and lymph nodes. Some patients may receive PET scans, which use a radioactive substance to highlight areas of active cell growth. Endoscopic ultrasound (EUS) combines ultrasound technology with endoscopy to create detailed images of stomach wall layers and nearby lymph nodes, providing important staging information. Staging—determining how far the cancer has spread—directly influences treatment planning and prognosis discussion.

Lab work including blood tests provides additional information about liver and kidney function, nutritional status, and tumor markers (proteins produced by cancer cells). For example, the CEA and CA 19-9 markers are sometimes measured, though these aren't cancer-specific and can be elevated in benign conditions too.

Practical Takeaway: Write down questions about which tests your doctor recommends, why each test is needed, and what to expect during the procedure so you feel informed and prepared for diagnostic steps.

Treatment Options and Approaches

Treatment plans for gastric cancer vary significantly based on disease stage, overall health status, and patient preferences. Surgery is often a primary treatment component. Gastrectomy—removal of part or all of the stomach—may be recommended, depending on cancer location and extent. A partial gastrectomy removes the affected portion of the stomach, while a total gastrectomy removes the entire stomach. Surgeons also typically remove nearby lymph nodes since cancer may have spread to these areas. Post-surgery, the digestive system requires adaptation; the small intestine is often reconnected to allow food to bypass the stomach, and patients adjust to eating smaller, more frequent meals.

Chemotherapy uses drugs to kill cancer cells throughout the body. For gastric cancer, chemotherapy may be given before surgery (neoadjuvant therapy) to shrink tumors, after surgery (adjuvant therapy) to reduce recurrence risk, or as a primary treatment for advanced disease that cannot be surgically removed. Common gastric cancer chemotherapy regimens include fluorouracil-based combinations, sometimes with platinum agents like cisplatin or oxaliplatin. Chemotherapy typically involves multiple treatment cycles with recovery periods between them, spanning several months. Side effects vary but may include nausea, hair loss, fatigue, and increased infection risk due to low white blood cell counts.

Radiation therapy uses high-energy beams to target cancer cells. It may be combined with chemotherapy for certain patients, particularly those with locally advanced disease. Targeted therapy and immunotherapy represent newer treatment approaches. Some gastric cancers have specific genetic mutations or protein expressions (like HER2 overexpression or microsatellite instability) that make them responsive to targeted drugs like trastuzumab. Immune checkpoint inhibitors help the body's immune system recognize and attack cancer cells and may be used in certain gastric cancer cases, particularly in advanced disease.

Treatment decisions involve multidisciplinary teams including surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists, and nurses. Each patient's plan is individualized based on staging information, performance status (overall ability to tolerate treatment), and personal preferences regarding treatment intensity and lifestyle considerations.

Practical Takeaway: Understanding treatment categories and asking your doctors which specific approaches are being recommended for your cancer stage helps you understand the reasoning behind your personalized treatment plan.

Managing Side Effects and Maintaining Quality of Life

Cancer treatment for gastric cancer can cause various side effects that affect daily life. Managing these effectively improves treatment tolerance and overall well-being. Nausea and vomiting rank among